Artemether-Lumefantrine Versus Chloroquine for the Treatment of Uncomplicated Plasmodium knowlesi Malaria: An Open-Label Randomized Controlled Trial CAN KNOW

BACKGROUND: Plasmodium knowlesi is reported increasingly across Southeast Asia and is the most common cause of malaria in Malaysia. No randomized trials have assessed the comparative efficacy of artemether-lumefantrine (AL) for knowlesi malaria. METHODS: A randomized controlled trial was conducted i...

Descripción completa

Detalles Bibliográficos
Autores principales: Grigg, Matthew J, William, Timothy, Barber, Bridget E, Rajahram, Giri S, Menon, Jayaram, Schimann, Emma, Wilkes, Christopher S, Patel, Kaajal, Chandna, Arjun, Price, Ric N, Yeo, Tsin W, Anstey, Nicholas M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Articles and Commentaries
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5790171/
https://www.ncbi.nlm.nih.gov/pubmed/29020373
http://dx.doi.org/10.1093/cid/cix779

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5790171/
https://www.ncbi.nlm.nih.gov/pubmed/29020373
http://dx.doi.org/10.1093/cid/cix779

Ejemplares similares